1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Posters by Title

Showing 1,267 results.

Thumbnail for Marrow-Dominant Aggressive Progression of TP53-Altered CLL/SLL After Reactive Myelofibrosis: A Diagnostic and Therapeutic Challenge

CLL - 620

Marrow-Dominant Aggressive Progression of TP53-Altered CLL/SLL After Reactive Myelofibrosis: A Diagnostic and Therapeutic Challenge

Adela Perolla

Poster Presenter: Adela Perolla

AML - 1263

Maternal and Fetal Outcomes in Non-APL Acute Myeloid Leukemia During Pregnancy: A Patient-Level Analysis

Felipe Soto

Poster Presenter: Felipe Soto

$Thumbnail for Measurable Residual Disease by Circulating Tumor DNA in Patients With Third-Line or Later Relapsed or Refractory Follicular Lymphoma Treated With Lisocabtagene Maraleucel (Liso-Cel) in TRANSCEND FL$

SOHO 2026 Annual Meeting

Posters by Title

Marrow-Dominant Aggressive Progression of TP53-Altered CLL/SLL After Reactive Myelofibrosis: A Diagnostic and Therapeutic Challenge

Maternal and Fetal Outcomes in Non-APL Acute Myeloid Leukemia During Pregnancy: A Patient-Level Analysis

Measurable Residual Disease by Circulating Tumor DNA in Patients With Third-Line or Later Relapsed or Refractory Follicular Lymphoma Treated With Lisocabtagene Maraleucel (Liso-Cel) in TRANSCEND FL

Measurable Residual Disease- Guided Therapeutic Strategies and Survival Outcomes in Hematologic Malignancies: A Systematic Review and Meta-Analysis of Leukemia and Lymphoma Trials

Medicaid Expansion and Access to Allogeneic Transplantation in Adults With Acute Leukemias.

Melatonin Enhances Venetoclax Sensitivity Through Modulation of Apoptotic and Resistance Pathways in Acute Myeloid Leukemia

Menin Inhibitors in NPM1 Mutations and KMT2A Rearrangements in Acute Myeloid Leukemia: Differential Efficacy Across Frontline and Relapsed Settings-A Systematic Review and Meta-Analysis

Menin Inhibitors vs FLT3 Inhibitor-Based Therapy in NPM1-Mutated Relapsed/Refractory AML: Comparative Efficacy, MRD Depth, and Safety Profiles

Mental Health and Malignancy: Real-World Associations Between Early-Onset Multiple Myeloma and Mental Illness